Taro Pharmaceutical
TARO
#5314
Rank
C$2.27 B
Marketcap
C$60.51
Share price
0.00%
Change (1 day)
8.56%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): C$0.82

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is C$1.72. In 2021 the company made an earnings per share (EPS) of C$0.05633 an increase over its 2020 EPS that were of C-$11.14.

EPS history for Taro Pharmaceutical from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$0.82
2021C$0.05633-100.51%
2020C-$11.14-222.45%
2019C$9.10-18.02%
2018C$11.1053.01%
2017C$7.25-55.95%
2016C$16.46-13.41%
2015C$19.0136.92%
2014C$13.8837.71%
2013C$10.0821.15%
2012C$8.3244.15%
2011C$5.77175.17%
2010C$2.10-48.8%
2009C$4.10
2005C$0.04225-91.89%
2004C$0.52-82.55%
2003C$2.9935.9%
2002C$2.2039.29%
2001C$1.58140.86%
2000C$0.6569.09%
1999C$0.39139.13%
1998C$0.1664.29%
1997C$0.09857-36.36%
1996C$0.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.41 447.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.39 330.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.07-37.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.40-18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.05 135.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.89-48.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel